Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis
Journal of Investigative Dermatology · 2024-01 · 144 (1) · 53-62.e2
DOI: 10.1016/j.jid.2023.06.201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024-01. Verfasst von Tao Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Bethune Charitable Foundation, National Natural Science Foundation of China, shaanxi sheng kexue jishu ting.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a common chronic inflammatory skin disease characterized by T helper 2 inflammation as the core pathogenic mechanism. MRGPRX2 plays a key role in nonhistamine allergies and neuroimmune mechanisms in chronic inflammatory dermatitis. However, the role of MRGPRX2 in AD and the development of type 2 inflammation is not yet clear. This study aimed to define the role of MRGPRX2 in type 2 inflammation development and cytokine release in AD by determining its levels in patients with AD and healthy controls. Furthermore, MrgprB2-conditional knockout (MrgprB2-/-) and wild-type mice were used to construct an MC903-induced AD mouse model to observe skin inflammation and cytokine release. Tryptase and its antagonist were applied separately to MrgprB2-/- mice with AD and wild-type mice with AD to confirm the role of the MRGPRB2-tryptase axis in the development of type 2 inflammation in AD. We found that AD severity and type 2 cytokine levels were not associated with IgE levels but were associated with MRGPRX2/MRGPRB2 expression. MrgprB2-/- mice with AD showed milder phenotypes and inflammatory infiltration in the skin than wild-type mice with AD. Tryptase released by MRGPRX2/MRGPRB2 activation is involved in the release of type 2 cytokines, which contributes to inflammatory development in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China.
- Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China; Center for Dermatology Disease, Precision Medical Institute, Xi'an, China.
- Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China. Electronic address: gengsongmei73@163.com.
Förderung
- Bethune Charitable Foundation
- National Natural Science Foundation of China
- shaanxi sheng kexue jishu ting
Zitieren
APA
Jia, T., Che, D., Zheng, Y., Zhang, H., Li, Y., Zhou, T., Peng, B., Du, X., Zhu, L., An, J., & Geng, S. (2024). Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis. Journal of Investigative Dermatology, 144(1), 53-62.e2. https://doi.org/10.1016/j.jid.2023.06.201
Vancouver
Jia T, Che D, Zheng Y, Zhang H, Li Y, Zhou T, et al. Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis. Journal of Investigative Dermatology. 2024;144(1):53-62.e2. doi:10.1016/j.jid.2023.06.201
BibTeX
@article{Jia2024,
author = {Jia, Tao and Che, Delu and Zheng, Yi and Zhang, Huan and Li, Yaxiang and Zhou, Tong and Peng, Bin and Du, Xueshan and Zhu, Longfei and An, Jingang and Geng, Songmei},
title = {Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis},
journal = {Journal of Investigative Dermatology},
year = {2024},
volume = {144},
number = {1},
pages = {53--62.e2},
doi = {10.1016/j.jid.2023.06.201}
}
EUVIMED